Clinical trial

Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy

NCT06450106

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-05-08

PhasePHASE1

Study timeline

Study start (actual)2025-05-08Date precision: day

Registry last updated2026-02-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

STM-416pDRUG

Sponsors & collaborators

SURGE Therapeuticslead sponsor

Mapped research locations

TucsonArizona, United States1 GainesvilleFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06450106 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.